EGFR and non-small cell lung carcinoma: Indeed, FAK, a very important cancer-promoting molecule in cancer, is involved in a variety of cancer signalling pathways [42, 43], and αV-FAK has been demonstrated to be related to the resistance of EGFR mutated non-small-cell lung cancer [38].